The Board of Directors of KOSÉ Corporation approved a resolution to establish KOSÉ Maruho Pharma Co., Ltd. on the same day. The formation of this company, which is a KOSÉ subsidiary jointly owned with Maruho Co., Ltd., is based on the agreement with Maruho that was announced by KOSÉ on January 31, 2019. KOSÉ Maruho Pharma will perform planning, development, marketing and sales activities for consumer healthcare products in the markets of over-the-counter drugs (quasi-drugs) and cosmetics by using both the cosmetics value of KOSÉ and the pharmaceutical value of Maruho. The new company will also function as a platform for planning a variety of other activities for the long-term success of this alliance between KOSÉ and Maruho.